Not applicableActive Not RecruitingNCT00898456What this trial is testingMultidrug Resistance Genes in Patients With Acute Myeloid LeukemiaWho this might be right forLeukemia Alliance for Clinical Trials in Oncology 600
Early research (Phase 1)Study completedNCT01246622What this trial is testingLenalidomide and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaWho this might be right forAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+4 more Roswell Park Cancer Institute 32
Testing effectiveness (Phase 2)Study completedNCT00387322What this trial is testingPemetrexed Disodium and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid TumorsWho this might be right forLung CancerUnspecified Adult Solid Tumor, Protocol Specific University of California, Davis 42
Early research (Phase 1)Study completedNCT00355472What this trial is testingPhase I Study of KW-0761 in Relapsed Patients With CCR4-Positive ATL and PTCLWho this might be right forAdult T-Cell Leukemia and Lymphoma (ATL)Adult Peripheral T-Cell Lymphoma (PTCL) Kyowa Kirin Co., Ltd. 16
Post-approval studies (Phase 4)WithdrawnNCT05183139What this trial is testingIn-class Transition Study of Ixazomib Combined With Pomalidomide and Dexamethasone or With Lenalidomide and Dexamethasone in Adults With Relapsed/Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Takeda
Early research (Phase 1)Study completedNCT03125239What this trial is testingCombination Merestinib and LY2874455 for Patients With Relapsed or Refractory Acute Myeloid LeukemiaWho this might be right forRelapsed Adult Acute Myeloid LeukemiaRefractory Adult Acute Myeloid Leukemia Jacqueline Garcia, MD 16
Testing effectiveness (Phase 2)Looking for participantsNCT04197297What this trial is testingBrain Imaging Biomarkers in Patients With Brain MetastasisWho this might be right forBrain Metastases, Adult University Health Network, Toronto 90
Testing effectiveness (Phase 2)Study completedNCT00044889What this trial is testingPhase II Study of Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous LeukemiaWho this might be right forAcute Myelogenous Leukemia Genzyme, a Sanofi Company 40
Not applicableStudy completedNCT00255697What this trial is testingQuality of Life of Older Patients Who Are Undergoing Treatment for Cancer and of Their Family CaregiversWho this might be right forPsychosocial Effects of Cancer and Its TreatmentUnspecified Adult Solid Tumor, Protocol Specific Case Comprehensive Cancer Center 863
Early research (Phase 1)Study completedNCT03441100What this trial is testingTCR-engineered T Cells in Solid Tumors: IMA202-101Who this might be right forSolid Tumor, AdultRefractory CancerRecurrent Cancer+1 more Immatics US, Inc. 16
Early research (Phase 1)Study completedNCT05508100What this trial is testingDose Confirmation and Dose Expansion Phase 1 Study of IO-108 and IO-108 + Anti-PD-1 in Solid TumorsWho this might be right forAdvanced Solid Tumor Immune-Onc Therapeutics 38
Early research (Phase 1)Study completedNCT00003144What this trial is testingChemotherapy and Amifostine in Treating Patients With Recurrent or Refractory Solid TumorsWho this might be right forDrug/Agent Toxicity by Tissue/OrganUnspecified Adult Solid Tumor, Protocol Specific NYU Langone Health 44
Early research (Phase 1)Study completedNCT00006009What this trial is testingMonoclonal Antibody Therapy in Treating Patients With Advanced or Recurrent LymphomaWho this might be right forLymphomaSmall Intestine Cancer Stanford University
Early research (Phase 1)Study completedNCT01567709What this trial is testingAlisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell LymphomaWho this might be right forAdult B Acute Lymphoblastic LeukemiaAdult T Acute Lymphoblastic LeukemiaAnaplastic Large Cell Lymphoma+32 more National Cancer Institute (NCI) 34
Early research (Phase 1)Study completedNCT00003409What this trial is testingMotexafin Gadolinium Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeWho this might be right forBrain and Central Nervous System Tumors Jonsson Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT01264432What this trial is testingVeliparib and Radiation Therapy in Treating Patients With Advanced Solid Malignancies With Peritoneal Carcinomatosis, Epithelial Ovarian, Fallopian, or Primary Peritoneal CancerWho this might be right forAdult Solid NeoplasmPeritoneal CarcinomatosisRecurrent Fallopian Tube Carcinoma+2 more National Cancer Institute (NCI) 34
Early research (Phase 1)Study completedNCT01014598What this trial is testingCisplatin in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer or Lung MetastasisWho this might be right forMetastatic Malignant Neoplasm in the LungStage IIIB Non-Small Cell Lung CancerStage IV Adult Soft Tissue Sarcoma+1 more Roswell Park Cancer Institute 11
Early research (Phase 1)Study completedNCT01169298What this trial is testingA Phase I, Multicenter, Open-label, Dose-escalation Study to Assess the Safety of Lenalidomide in Patients With Advanced Adult T-cell Leukemia-lymphoma and Peripheral T-cell Lymphomaperipheral T-cell LymphomaWho this might be right forAdult T-cell Leukemia-LymphomaPeripheral T-cell Lymphoma Celgene 13
Testing effectiveness (Phase 2)Study completedNCT00003572What this trial is testingTotal-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic CancersWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 20
Testing effectiveness (Phase 2)Study completedNCT00006357What this trial is testingSTI571 in Treating Patients With Recurrent or Refractory Soft Tissue SarcomaWho this might be right forEndometrial CancerGastrointestinal Stromal TumorOvarian Cancer+2 more European Organisation for Research and Treatment of Cancer - EORTC 91